The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada.
about
The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@en
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@nl
type
label
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@en
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@nl
prefLabel
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@en
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@nl
P2093
P2860
P356
P1433
P1476
The cost-effectiveness of beva ...... nced ovarian cancer in Canada.
@en
P2093
P2860
P304
P356
10.3747/CO.23.3139
P577
2016-10-25T00:00:00Z